Date	Article
17 Dec 2002	Oxford BioMedica plc Awarded $0.5 Million Grant for Motor Neuron Disease Programme
14 Nov 2002	David Higgins Appointed Vice President for Business Development
8 Nov 2002	Update on Cancer Clinical Plans
24 Oct 2002	Collaboration Attracts First Development Partner in Protein Design Labs Inc.
17 Sep 2002	Oxford BioMedica Appoints Nick L Woolf Senior Vice President of Corporate Strategy
28 Aug 2002	Oxford BioMedica Interim Results for the Six Months Ended 30 June 2002
25 Jul 2002	Oxford BioMedica plc and ARIUS Research Inc. Sign Collaborative Programme in Tumour Immunotherapy
11 Jul 2002	Oxford BioMedica's Trovax® Poised to Enter Phase II Trials
25 Jun 2002	Oxford BioMedica Joins The Fight Against Lou Gehrig's Disease
10 Jun 2002	Oxford BioMedica and Imperial College Announce Breakthrough in Gene Therapy Technology
06 Jun 2002	Oxford BioMedica: Successful Preclinical Results for New Anaemia Product
08 May 2002	Oxford BioMedica plc and Institute of Ophthalmology New Research Collaboration
01 May 2002	Changes to Board
27 Feb 2002	Preliminary Results for the Year Ended 31 December 2001
20 Feb 2002	Interim Clinical Results - MetXia® and TroVax®

Website by College Hill - Life Sciences